An efficient asymmetric synthesis of an estrogen receptor modulator by sulfoxide-directed borane reduction.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 15079059.
- Also identified by PMC identifier 395984.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
An efficient asymmetric synthesis of a selective estrogen receptor modulator (SERM) that has a dihydrobenzoxathiin core structure bearing two stereogenic centers is reported. The stereogenic centers were established by an unprecedented chiral sulfoxide-directed stereospecific reduction of an alpha,beta-unsaturated sulfoxide to the saturated sulfide in one step. Studies to elucidate the mechanism for this reduction are reported. Highly efficient Cu(I)-mediated ether formation was used to install the ether side chain, and selective debenzylation conditions were developed to remove the benzyl protecting groups on the phenols.
Medical subject headings
- Boranes
- Estrogen Receptor Modulators
- Safrole